A novel method for evaluation of improved survival trend for common cancer: Early detection or improvement of medical care

Journal of Evaluation in Clinical Practice

Volumn 13, Issue 1, 2007, Pages 79-85

  Chie, Wei Chu ^a   Chang, Yi Hsin ^a   Chen, Hsiu Hsi ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Advances in medical technology; Attributable proportion; Cancer survival; Early detection

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; EVALUATION; FEMALE; HUMAN; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; PRIORITY JOURNAL; PROSTATE CANCER; STOMACH CANCER; SURVIVAL RATE; UTERINE CERVIX CANCER;

DATA DISPLAY; HUMANS; NEOPLASM STAGING; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; QUALITY OF HEALTH CARE; REGISTRIES; SURVIVAL RATE; TAIWAN;

EID: 33846918914     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2006.00656.x     Document Type: Article

References (11)

1. Tabar, L., Fagerberg, C. J., Gad, A., et al. (1985) Reduction in mortality from breast cancer after mass screening with mammography. Lancet, I, 829-832.
2. Nystrom, L., Rutqvist, L. E., Wall, S., et al. (1993) Breast cancer screening with mammography: overview of Swedish randomized trials. Lancet, 341, 973-978.
3. Fisher, B., Dignam, J., Bryant, J. & Wolmark, N. (2001) Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial. Journal of the National Cancer Institute, 93, 684-690.
4. Van Oortmarssen, G. J., Boer, R. & Habbema, J. D. (1995) Modeling issues in cancer screening. Statistical Methods in Medical Research, 4, 33-54.
5. Mandel, J. S., Bond, J. H., Church, T. R., Snover, D. C., Bradley, G. M., Schuman, L. M. & Ederer, F. (1993) Reducing mortality from colorectal cancer by screening for fecal occult blood. New England Journal of Medicine, 328, 1365-1371.
6. Hardcastle, J. D., Chamberlain, J. O., Robinson, M. H., Moss, S. M., Amar, S. S., Balfour, T. W., James, P. D. & Mangham, C. M. (1996) Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet, 348, 1472-1477.
7. Kronborg, O., Fenger, C., Olsen, J., Jorgensen, O. D. & Sondergaard, O. (1996) Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet, 348, 1467-1471.
8. Kapiteijn, E. & van de Velde, C. J. (2002) The role of total mesorectal excision in the management of rectal cancer. Surgical Clinics of North America, 82, 995-1007.
9. Chen, T. H. H., Chen, C. J., Yen, M. F., Lu, S. N., Sun, C. A., Huang, G. T., Yang, P. M., Lee, H. S. & Duffy, S. W. (2002) Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan. International Journal of Cancer, 98, 257-261.
10. Louw, J. A., Kidd, M. S., Kummer, A. F., Taylor, K., Kotze, U. & Hanslo, D. (2001) The relationship between Helicobacter pylori infection, the virulence genotypes of the infecting strain and gastric cancer in the African setting. Helicobacter, 6, 268-273.
11. Yamaguchi, N. & Kakizoe, T. (2001) Synergistic interaction between Helicobacter pylori gastritis and diet in gastric cancer. Lancet Oncology, 2, 88-94.